PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
01-Apr-2022 Spexis publishes invitation to Annual General Meeting 2022 Spexis AG
01-Apr-2022 Relief Reports that its U.S. Collaboration Partner has Announced that the I-SPY COVID Trial Suggests No Clinical Benefit with Addition of Nebulized Aviptadil in Critically Ill Patients with COVID-19 Relief Therapeutics Holding SA
01-Apr-2022 PolyPeptide publishes invitation to the annual General Meeting 2022 PolyPeptide Group
01-Apr-2022 Straumann Group announces new Executive Management Board members to support growth strategy Straumann Holding AG
31-Mar-2022 Iktos Announces a Collaboration With Ono in Artificial Intelligence for New Drug Design Iktos
31-Mar-2022 Novartis UK response to NICE Appraisal Consultation Document (ACD) for Piqray (alpelisib) for advanced breast cancer patients Novartis
31-Mar-2022 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Launches Capital Increase by Way of Private Placement (news with additional features) Vivoryon Therapeutics N.V.
31-Mar-2022 Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH) M1 Kliniken AG
31-Mar-2022 Immutep’s efti in combination with MSD’s pembrolizumab shows encouraging antitumor activity in difficult to treat second line metastatic lung cancer patients Immutep Limited
31-Mar-2022 Fitabeo Therapeutics shortlisted for National StartUp Award Fitabeo Therapeutics
31-Mar-2022 V-Bio Ventures raises EUR 110 million for its second fund and expands team V-Bio Ventures
31-Mar-2022 Sanofi successfully priced an inaugural sustainability-linked bond indexed on access to medicines Sanofi
31-Mar-2022 Pharma Business Development: In-person Format Clearly Beats Video Conferencing RauCon GmbH & Co. KG
31-Mar-2022 Maruho Deutschland GmbH: Statement of Maruho Deutschland GmbH on the proposed capital measures in the context of the Extraordinary General Meeting on 7 April 2022 Maruho Deutschland GmbH
31-Mar-2022 Turnaround in FY/2021: Significant sales growth (+30%) and substantially improved EBIDTA (+84%) - clear trend towards black zero aap Implantate AG
31-Mar-2022 Relief Reports Full-Year 2021 Results and Provides Corporate Update Relief Therapeutics Holding SA
31-Mar-2022 AEVIS VICTORIA SA achieved very strong results on its investments in 2021 with a holding income of CHF 216.4 million and a net profit of CHF 197.6 million AEVIS VICTORIA SA
30-Mar-2022 MediClin AG: Group sales and Group operating result in the second year of Corona above previous year - cautious outlook for year 2022 MediClin AG
30-Mar-2022 Immutep’s efti in combination with MSD’s pembrolizumab shows encouraging antitumor activity in difficult to treat second line metastatic lung cancer patients Immutep Limited
30-Mar-2022 SABINA programme demonstrates SABA reliever overuse is a global issue in asthma management AstraZeneca